Description
A BH3 mimetic that selectively inhibits Bcl-2 (Ki 3-fold less avidly to the related family proteins, Bcl-xL and Bcl-W (Kis = 48 and 245 nM, respectively); inhibits the growth of Bcl-2-dependent cell lines and in vivo tumor xenografts and demonstrates antileukemic activity in patients with refractory chronic lymphocytic leukemia
Formal name: 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzamide
Synonyms: GDC 0199
Molecular weight: 868.4
CAS: 1257044-40-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Death|Apoptosis